TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Enzyme Research
New findings reported from D. Ivanova and co-authors describe advances in enzyme research
September 30th, 2008
A new study, 'Extended-spectrum beta-lactamase-producing Serratia marcescens outbreak in a Bulgarian hospital,' is now available. "We describe a nosocomial outbreak of extended-spectrum beta-lactamase (ESBL)-producing Serratia marcescens in a Bulgarian university hospital affecting nine patients on four wards. Phenotypic and genotypic (plasmid profile, randomly amplified polymorphic DNA analysis and amplified ribosomal DNA restriction analysis) analysis of the isolates indicated a single clone," scientists in Sofia, Bulgaria report. "The epidemic strain was resistant to oxyimino beta-lactams, aztreonam, aminoglycosides, tetracycline and chloramphenicol. It...
Source: TB & Outbreaks Week (2008-09-30)
|
